Durable and Drastic Response to the Trastuzumab, Letrozole, Abemaciclib, and Goserelin Combination as First-Line Therapy in HER2-Positive and Hormone Receptor-Positive Metastatic Breast Cancer: A Case Report.

Item request has been placed!

Item request cannot be made.

Processing Request

Read Online Read More Add to Saved list

Author(s): Suwanvecho, Suthida¹ (AUTHOR); Kiatikajornthada, Narongsak¹ (AUTHOR); Phikulsod, Ployploen² (AUTHOR); Suwanrusme, Harit¹ (AUTHOR); Jirawatnotai, Siwanon³ (AUTHOR)
Source:
Case Reports in Oncology. Jan2025, Vol. 18 Issue 1, p130-136. 7p. 1 Illustration.